tAby DIAGNOSTICS
29 octubre 2020Disruptive Technology
Increasing Tumor Associated Antigens Immunogenicity

OUR PRODUCTS
yliver is a blood test that detects alpha-fetoprotein autoantibodies. Taby diagnostics provides this test to hospitals and associated laboratories to early diagnose liver cancer with a sensitivity of 100% and a specificity of 94%
OUR TECHNOLOGY
Taby diagnostics tecnhology increases the immunogenicity of tumor-associated antigens
MÁS ARTÍCULOS

SUCCIPRO, a new probiotic strategy for obesity-related disorders

INCLIVA recibe financiación de FIPSE para el desarrollo de un test de diagnóstico y pronóstico rápido…

Liquorféresis extracorpórea (Fundación de neurociencias)
